Protein and/or peptide modification molecule

US2022204481A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2022204481-A1
Application numberUS-202017432838-A
CountryUS
Kind codeA1
Filing dateFeb 28, 2020
Priority dateFeb 28, 2019
Publication dateJun 30, 2022
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An object of the present invention is to provide a technique that allows other molecules/substances to be more selectively linked to the N-terminus in a simple and efficient manner, even in natural proteins etc. This object is achieved by reacting a compound represented by formula (1) or a salt thereof, or a hydrate or solvate of the compound or a salt thereof with a protein and/or peptide.

First claim

Opening claim text (preview).

In the claims: 1 . A reagent for protein and/or peptide modification, comprising a compound represented by formula (1) or a salt thereof, or a hydrate or solvate of the compound or a salt thereof, wherein one of R 1 and R 2 represents —N(—R 4 )— (wherein R 4 represents an organic group or a group derived from an inorganic material), and the other represents ═N—; and R 3 represents a hydrogen atom, an organic group, or a group derived from an inorganic material. 2 . The reagent according to claim 1 , wherein the compound is represented by formula (1A): wherein R 4 is as defined above. 3 . The reagent according to claim 1 , wherein the organic group is a group derived from an organic molecule or an organic molecular complex, and the organic molecule or the organic molecular complex is a functional substance. 4 . The reagent according to claim 3 , wherein the functional substance is a pharmaceutical compound, a luminescent molecule, a macromolecular compound, a ligand, a molecule to which a ligand binds, an antigenic protein, an antibody, a protein, a nucleic acid, a saccharide, a lipid, a cell, a virus, a label, a carbon electrode, a carbon nanomaterial, a linker, a spacer molecule, or a complex or linked molecule thereof. 5 . The reagent according to claim 1 , wherein the inorganic material is an electrode material, metal fine particles, metal oxide fine particles, semiconductor particles, or magnetic particles. 6 - 8 . (canceled) 9 . A method for producing a compound represented by formula (1) or a salt thereof, or a hydrate or solvate of the compound or a salt thereof, wherein one of R 1 and R 2 represents —N(—R 4 )— (wherein R 4 represents an organic group or a group derived from an inorganic material), and the other represents ═N—; and R 3 represents a hydrogen atom, an organic group, or a group derived from an inorganic material, the method comprising: reacting a compound represented by formula (5): R 4 -R 9 (5), wherein R 4 represents an organic group or a group derived from an inorganic material; and R 9 represents —NR 9a R 9b (wherein R 9a and R 9b are the same or different and each represents a hydrogen atom or an alkyl group), with a compound represented by formula (6): wherein R 10 represents an electron-withdrawing group; R 11 represent —R 11a —R 12 (wherein R 11a represents a single bond or a linker; and R 12 represents a carrier); n represents 0 or 1; and m represents an integer of 1 to 5. 10 . A compound represented by formula (6′): wherein R 10 represents an electron-withdrawing group; R 11a represents a single bond or a linker; R 12 represents a carrier; and m represents an integer of 1 to 5. 11 . A compound represented by formula (7) or a salt thereof, or a hydrate or solvate of the compound or a salt thereof, wherein one of R 1 and R 2 represents —N(—R 4 )— (wherein R 4 represents an organic group or a group derived from an inorganic material), and the other represents ═N—; R 3 represents a hydrogen atom, an organic group, or a group derived from an inorganic material; a double line composed of a dotted line and a solid line represents a single bond or a double bond; R 13 represents a group in which the N-terminal amino acid residue and —NH— adjacent thereto are excluded from a protein or peptide; and R 14 represents the side chain of the N-terminal amino acid residue of the protein or peptide. 12 . A method for producing the compound or a salt thereof, or a hydrate or solvate of the compound or a salt thereof according to claim 11 , the method comprising reacting a protein and/or a peptide with a compound represented by formula (1) or a salt thereof, or a hydrate or solvate of the compound or a salt thereof, wherein one of R 1 and R 2 represents —N(—R 4 )— (wherein R 4 represents an organic group or a group derived from an inorganic material), and the other represents ═N—; and R 3 represents a hydrogen atom, an organic group, or a group derived from an inorganic material.

Assignees

Inventors

Classifications

  • the carrier being a synthetic polymer · CPC title

  • Production of labelled immunochemicals · CPC title

  • 1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles · CPC title

  • C07D403/12Primary

    linked by a chain containing hetero atoms as chain links · CPC title

  • Ortho-condensed systems · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2022204481A1 cover?
An object of the present invention is to provide a technique that allows other molecules/substances to be more selectively linked to the N-terminus in a simple and efficient manner, even in natural proteins etc. This object is achieved by reacting a compound represented by formula (1) or a salt thereof, or a hydrate or solvate of the compound or a salt thereof with a protein and/or peptide.
Who is the assignee on this patent?
Univ Osaka
What technology area does this patent fall under?
Primary CPC classification C07D403/12. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Jun 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).